Results 201 to 210 of about 473,635 (345)

Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development

Clinical Pharmacology &Therapeutics, EarlyView.
When the acquired immunodeficiency syndrome emerged in the 1980s, the United States National Institutes of Health established research networks to conduct clinical trials with the pharmaceutical industry to identify effective antiretroviral therapeutics.
Robin DiFrancesco, Troy D. Wood, Raymond Cha, Jill S. Hochreiter, Susan L. Rosenkranz, Mona Farhad, Kyle R. Whitson, Connor E. Gould, Lauren E. Hill, Linda L. Hale, Philip H. Lindhorst, Diala Ghazal, Charlene R. Taylor, Madiha Quraishi, Suzanne M. Siminski, Yoninah Cramer, Heather L. Sprenger, Gene D. Morse   +17 more
wiley   +1 more source

Presence of Hepatitis E Virus in a RED Deer (Cervus elaphus) Population in Central Italy

, 2015
Ilaria Di Bartolo, Eleonora Ponterio, Giorgia Angeloni, Federico Morandi, Fabio Ostanello, S. Nicoloso, Franco Maria Ruggeri   +6 more
openalex   +2 more sources

The Squalene Oil‐in‐Water Nanoemulsion Vaccine Carrier AddaVax Potentiates TLR‐Induced B‐Cell Responses

Cytometry Part A, EarlyView.
ABSTRACT For vaccination, the mechanisms of action of antigens and of immunostimulatory pathogen‐associated molecular pattern (PAMP) adjuvants are better understood than the roles of the depot, carrier, and other formulation‐related influences. Here, we carried out cytometric studies of vaccine formulations and the effect of adjuvant formulations on B ...
Egest J. Pone, Jiin Felgner, Jenny Hernandez‐Davies, D. Huw Davies   +3 more
wiley   +1 more source

Environmental considerations in hepatitis E virus transmission: Is there a missing link? [PDF]

World J Hepatol
Campbell R, Russell C, Izopet J, Nassim K, Sonderup M, Pischke S, Wallace SJ, Madden RG.   +7 more
europepmc   +1 more source

Nanoparticles in microdroplets: Recent advances in microfluidic generators for producing functional microbeads

Droplet, EarlyView.
Functional hybrid microbeads with electrical, magnetic, and/or optical responsiveness have emerged as versatile platforms for biotechnology. This review highlights recent advances in microfluidic technologies for producing such microbeads, with a focus on incorporating functional nanoparticles in microdroplet systems.
  Bayinqiaoge, Chengchen Zhang, Shi‐Yang Tang   +2 more
wiley   +1 more source

Effects of intraduodenally applied bile salts on pancreatic secretion [PDF]

, 1993
Lehnert, Peter, Riepl, Rudolf L.
core   +1 more source

Recurrent Hepatitis E in Pregnancy

Pakistan Journal of Medicine and Dentistry
Hepatitis E virus (HEV) is a single stranded RNA virus that causes large scale epidemics of acute viral hepatitis, particularly in developing couniries.
Rehana Yasmeen’, Rubina Hussain, Anjum Afshan   +2 more
doaj  

Absence of hepatitis E virus in hedgehogs in northern Italy in 2022-2024. [PDF]

Virol J
Arnaboldi S, Benevenia R, Righi F, Scarazzato A, Lavazza A, Lelli D, Trogu T, Losio MN, Bertasi B.   +8 more
europepmc   +1 more source

Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling

Developmental Dynamics, EarlyView.
Abstract Background Sporadic venous malformation (VM) is associated with the hyperactivating p.L914F mutation in TIE2, a receptor tyrosine kinase essential for vascular development. This mutation is not found in hereditary VM, suggesting incompatibility with life when expressed during early vascular development.
Lindsay J. Bischoff, Sandra Schrenk, Kara Soroko, Chhiring Sherpa, Ashok Arasu, Damien Reynaud, Elisa Boscolo   +6 more
wiley   +1 more source

An Optimized High-Throughput Neutralization Assay for Hepatitis E Virus (HEV) Involving Detection of Secreted Porf2 [PDF]

, 2019
Chang Liu, Wei Cai, Xin Yin, Zimin Tang, Guiping Wen, Charuta Ambardekar, Xinlei Li, Ying Dong, Zongdi Feng, Zizheng Zheng, Ningshao Xia   +10 more
openalex   +1 more source